Roche operating profits rise 29% in first half

19 July 2007 08:29  [Source: ICIS news]

MUMBAI (ICIS news)--Swiss major Roche said on Thursday its operating profits before exceptional items rose 29% for the first half of 2007 as sales at its pharmaceuticals division grew three times the size of the global market average.

 

Operating profits before exceptional items totalled Swiss francs (Swfr) 7.5bn ($6.2bn), compared with Swfr5.8bn from the same period a year ago.

 

For the period Roche said its sales were up 15% to Swfr22.8bn. The company’s net income rose 29% to about Swfr5.9bn due to outstanding operating results and a further increase in net financial income, it added.

 

“Roche posted impressive half-year results, continuing the robust growth of previous years. Interim sales rose 15%, resulting in additional market share gains, particularly for the pharmaceuticals division,” Franz Humer, company chairman and CEO, said.

 

For the first half of the year the company’s pharmaceuticals business posted sales of about Swfr18.3bn, up 17% from a year ago.

 

Double-digit sales growth for the whole group, led by the pharmaceuticals division, was expected for full-year 2007, Roche said.

 

($1 = Swfr1.65)

By: Isha Jha
+65 6780 4359

< previous article(VIDEO - ICIS news Europe Lunchtime Bulletin 2 November 2009)

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly